ArticleFrontiers in molecular biosciences2023

One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.

Alice Castaldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.